Tag: The Lancet

ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...

Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...

Study reveals racial disparity in brain tumour surgeries recommended to US...

A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...

Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...

The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...

Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments

Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...

Tenecteplase shown to be effective for acute ischaemic stroke in large...

In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...
vivistim system

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...